Introduction
Stroke is among the five leading causes of death and severe long-term disabilities across the world. Approximately, more than one million individuals experience a new or a recurrent stroke every year and one out of ten deaths in the world are as a result of stroke in the world. Noteworthy interventions to lessen mortality and morbidity linked with ischemic stroke have been adopted centering on the early identification of stroke signs and management with clot dissolving substances, particularly, recombinant tissue plasminogen activator (rt-PA) (Graves et al, 2013). Research indicates that when rt-PA is dispensed within 4 and half hours after the first ...